RRoche Read More Roche to present 45 ophthalmology studies at ARVO2026-04-30 Roche (OTCQX: RHHBY) will present more than 45 abstracts at ARVO 2026 (3–7…
RRoche Read More Roche’s Contivue Earns CE Mark for Continuous Eye Disease Treatment2026-02-17 Roche (OTCQX:RHHBY) has received CE mark approval for Contivue, its Port Delivery Platform…